Get started
Author

Marie de Zélicourt

Observed names: M D Zélicourt, M De Zelicourt, M de Zélicourt, M. De Zelicourt, M. de Zelicourt, M. de Zélicourt, Marie De Zelicourt, Marie de Zelicourt, Zélicourt, Marie de
Institution: Cemka-Eval (France)
ORCID: 0000-0002-1259-9642
Observed ORCID: 0000-0002-1259-9642
OpenAlex ID: A5000750776
The contributing factors to medical cost of epilepsy: an estimation based on a French prospective cohort study of patients with newly diagnosed epileptic seizures (the CAROLE study)
2000 · Marie de Zélicourt, Laurent Buteau, et al. · Seizure · 74
PDF
Cost of Care for Inpatients with Community-Acquired Intra-Abdominal Infections
2002 · P. Cattan, D. Yin, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 54
In-patient care costs of patients with bipolar I disorder: A comparison between two European centers
2009 · A.M. Gonzalez-Pinto, R. Dardennes, et al. · Journal of Affective Disorders · 40
Frequency of Hospitalisations and Inpatient Care Costs of Manic Episodes: In Patients with Bipolar I Disorder in France
2003 · Marie de Zelicourt, Roland Dardennes, et al. · PharmacoEconomics · 39
Management of focal epilepsy in adults treated with polytherapy in France: The direct cost of drug resistance (ESPERA study)
2014 · M. de Zélicourt, B. de Toffol, et al. · Seizure · 19
[Epidemiology and costs of lung cancer in France].
2001 · M D Zélicourt, B Detournay, et al. · PubMed · 14
Treatment patterns, risk factors and outcomes for patients with newly diagnosed hepatocellular carcinoma in France: A retrospective database analysis
2023 · Philippe Mathurin, Marie de Zélicourt, et al. · Clinics and Research in Hepatology and Gastroenterology · 13
Epidemiology and disease burden of tuberous sclerosis complex in France: A population‐based study based on national health insurance data
2022 · Francis Fagnani, Caroline Laurendeau, et al. · Epilepsia Open · 13
PDF
[Recurrent respiratory infections in patients with chronic obstructive bronchitis: medical treatment and costs].
1996 · M Pechevis, F Fagnani, et al. · PubMed · 13
Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting
2022 · Brooke Harrow, Francis Fagnani, et al. · Advances in Therapy · 12
PDF
[Bipolar I disorder in France: prevalence of manic episodes and hospitalisation-related costs].
2003 · M de Zélicourt, R Dardennes, et al. · PubMed · 7
Treatment Patterns and Survival in Patients with Intermediate, Advanced, or Terminal Stage of Hepatocellular Carcinoma in France over the Period 2015-2017: A Real-Life Study
2023 · Jean-Frédéric Blanc, Caroline Laurendeau, et al. · GastroHep · 4
PDF
Management and Health Resource Use of Patients With Metastatic Renal Cell Carcinoma treated With Systemic Therapy Over 2014-2017 in France: A National Real-World Study
2022 · Bernard Escudier, Marie de Zélicourt, et al. · Clinical Genitourinary Cancer · 4
PDF
ESPERA study: Applicability of the new ILAE criteria for antiepileptic drug resistance of focal epilepsies in current clinical practice
2012 · Bertrand de Toffol, Marie de Zélicourt, et al. · Epilepsy & Behavior · 4
Epilepsies and time to diagnosis
2000 · C. Cachera, Michel Baulac, et al. · Revue Neurologique · 4
Risk factors, treatment patterns and survival of patients with incident hepatocellular carcinoma in France: A retrospective data analysis.
2021 · Philippe Mathurin, Marie De Zelicourt, et al. · Journal of Clinical Oncology · 2
Patients adultes traités par une association d’antiépileptiques pour une épilepsie focale en France : description et mode de prise en charge selon les nouveaux critères de définition de la pharmacorésistance (étude ESPERA)
2014 · H. Vespignani, M. de Zélicourt, et al. · Revue Neurologique · 2
Impact de Xolair sur la consommation de soins en France : une analyse des données de l’EGB
2015 · M. Molimard, C. Thonnelier, et al. · Revue des Maladies Respiratoires · 1
Mortalité des sujets épileptiques vivant en institution spécialisée, en France
2008 · Pierre Jallon, Marie de Zélicourt, et al. · Epilepsies · 1
La mortalité observée à trois ans, dans l’enquête CAROLE
2007 · Pierre Jallon, Marie de Zélicourt, et al. · Epilepsies · 1
Frequency and hospitalisation-related costs of manic episodes in patients with bipolar I disorder in France
2002 · M. de Zelicourt, R. Dardennes, et al. · European Psychiatry · 1
Correction to: Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting
2022 · Brooke Harrow, Francis Fagnani, et al. · Advances in Therapy
PDF
Correction to: Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting
2022 · Brooke Harrow, Francis Fagnani, et al. · Advances in Therapy
PDF
PND13 Management of Focal Epilepsy Treated by Polytherapy in France: The Cost of Pharmaco-Resistance
2011 · M. de Zélicourt, C. Laurendeau, et al. · Value in Health
PND25 Use of Drug Reimbursement as Markers of Disease for Epidemiological and Direct Cost analysis: The Case of Epilepsy in France
2011 · F. Fagnani, O. Kusnik-Joinville, et al. · Value in Health
Works count: 26
Citation count: 322
H-index: 10
I10-index: 10
Year
Topic
Type